Aterian, INC Schedule 13D activist filings

David E. Lazar files an exit amendment to Schedule 13D, reporting a decrease in beneficial ownership below 5% following the conversion of preferred stock and sale of shares, indicating significant potential dilution.

David E. Lazar has acquired a controlling stake in Aterian, Inc. through convertible preferred stock, signaling a strategic shift and potential for significant corporate actions.